Predictions
Jumia Technologies AG
Start price
Target price
Perf. (%)
€22.00
11.07.21
11.07.21
€28.00
11.07.22
11.07.22
-74.14%
12.07.22
12.07.22
Could be worthwhile Investment >10% per year
Undervalued
Good culture
Capable Management
Revez Corporation Ltd.
Start price
Target price
Perf. (%)
€0.16
11.07.21
11.07.21
€2.00
11.07.22
11.07.22
-63.21%
12.07.22
12.07.22
Could be very worthwhile Investment >20% year
Undervalued
Normal challenges to pay loans and raise capital
Valuable balance sheet
Ocugen Inc.
Start price
Target price
Perf. (%)
€6.40
11.07.21
11.07.21
-
11.07.22
11.07.22
-56.90%
12.07.22
12.07.22
Probably not worthwhile Investment
Churchill Capital Corp. Iv
Start price
Target price
Perf. (%)
€24.12
11.07.21
11.07.21
€160.00
11.07.22
11.07.22
8.31%
12.07.22
12.07.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Dermapharm Holding SE
Start price
Target price
Perf. (%)
€69.00
10.07.21
10.07.21
-
10.07.22
10.07.22
-25.94%
11.07.22
11.07.22
Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
Nova Minerals Ltd.
Start price
Target price
Perf. (%)
€0.082
10.07.21
10.07.21
€0.000
10.07.22
10.07.22
496.95%
02.05.22
02.05.22
Aspermont Ltd.
Start price
Target price
Perf. (%)
€0.018
10.07.21
10.07.21
€0.000
10.07.22
10.07.22
-21.35%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
Antelope Enterprise Hldgs Ltd.
Start price
Target price
Perf. (%)
€3.28
10.07.21
10.07.21
€3.00
10.07.22
10.07.22
-26.22%
21.10.21
21.10.21
Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Hexagon Purus As
Start price
Target price
Perf. (%)
€3.87
10.07.21
10.07.21
€4.00
10.07.22
10.07.22
-18.60%
30.07.21
30.07.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
Desenio Holding Ab
Start price
Target price
Perf. (%)
€4.49
10.07.21
10.07.21
-
10.07.22
10.07.22
3.08%
24.07.21
24.07.21
EBIT decline/stagnation expected
Bad rating
negative Cash Flow expected
Bad culture
Livent Corp.
Start price
Target price
Perf. (%)
€16.95
10.07.21
10.07.21
€25.00
10.07.22
10.07.22
30.04%
11.07.22
11.07.22
EBIT growth > 30% per year expected
Fair valuation
Differentiated customer and product portfolio
Very low/no dividend yield expected
Powerhouse Energy Group Plc
Start price
Target price
Perf. (%)
€0.059
10.07.21
10.07.21
-
10.07.22
10.07.22
-61.63%
11.07.22
11.07.22
Tech & Energy Transition Corp.
Start price
Target price
Perf. (%)
€8.49
09.07.21
09.07.21
€10.00
09.07.22
09.07.22
16.05%
10.07.22
10.07.22
Could be worthwhile Investment >10% per year
Clover Health Inv. Corp.
Start price
Target price
Perf. (%)
€8.10
09.07.21
09.07.21
-
09.07.22
09.07.22
-15.93%
24.07.21
24.07.21
Risky Investment
Rovio Entertainment Oyj
Start price
Target price
Perf. (%)
€6.98
08.07.21
08.07.21
-
08.07.22
08.07.22
-7.67%
08.07.22
08.07.22
